Dr. Megan Stuebner Devine, MD

Dr. Devine practices at UT Health North Campus Tyler in Tyler, Texas, part of Ardent Health.

Dr. Devine's NPI, 1255541108, was assigned on May 22, 2007. Dr. Devine graduated from Emory School of Medicine in 2005. Dr. Devine holds Texas license M7948.

Dr. Devine's primary practice is UT Health North Campus Tyler, at 11937 Us Highway 271, Tyler, TX 75708 in Smith County. The practice phone is (903) 877-7777.

Dr. Devine's primary practice is UT Health North Campus Tyler in Tyler, Texas, part of Ardent Health. Dr. Devine is also affiliated with CHRISTUS Mother Frances Hospital - Tyler. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Devine to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devine practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Devine's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Devine is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Devine is licensed in Texas.

Dmand AI lists acute respiratory failure, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Devine treats.

CMS data shows 1,274 Medicare services from Dr. Devine across 16 procedure codes in 2024, for 322 Medicare patients. Medicare paid $36,609 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 322 Medicare patients who saw Dr. Devine in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have copd, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devine's median patient age at 72, with 68% women.

In 2024, Dr. Devine wrote 1,761 Medicare Part D claims for 247 patients. 51% of them were for generic drugs. CMS names the drug for 1,380 of them, across 39 drugs with 11 or more claims each, at $3,975,036 in total drug cost. In 2023, CMS named 1,296 claims across 36 drugs.

Dr. Devine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devine as offering telehealth.

Dmand AI links 5 papers to Dr. Devine, published from 2014 to 2025. Dr. Devine's most frequent co-authors are Julie V. Philley, MD, Amee Amin, MD and Fatimah Oluwakemi Bello, MD, MPH.

Dmand AI links Dr. Devine to 1 clinical trial. Conditions studied include alpha 1-Antitrypsin Deficiency and Subcutaneous Emphysema.

CMS Open Payments shows 322 general payments to Dr. Devine from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Genentech, Inc. paid the most, $3,746.

Dr. Devine graduated from Emory School of Medicine in 2005.

Dr. Devine is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.